Download PDF
CC BY-NC-ND 4.0 · J Hand Microsurg 2021; 13(02): 109-113
DOI: 10.1055/s-0040-1719228
Original Article

Factors Associated with Increased Risk of Recurrence following Treatment of Trigger Finger with Corticosteroid Injection

Frederik Flensted 
1   Department of Orthopedics, Hand Clinic, Herlev-Gentofte University Hospital of Copenhagen, Copenhagen, Denmark
,
Claus Hjorth Jensen
1   Department of Orthopedics, Hand Clinic, Herlev-Gentofte University Hospital of Copenhagen, Copenhagen, Denmark
,
Henrik Daugaard
1   Department of Orthopedics, Hand Clinic, Herlev-Gentofte University Hospital of Copenhagen, Copenhagen, Denmark
,
Jens-Christian Vedel
1   Department of Orthopedics, Hand Clinic, Herlev-Gentofte University Hospital of Copenhagen, Copenhagen, Denmark
,
Rasmus Wejnold Jørgensen
2   Department of Orthopedics, Herlev-Gentofte University Hospital of Copenhagen, Copenhagen, Denmark
› Author Affiliations Funding None.
› Further Information
    Permissions and Reprints

Abstract

Introduction  The aim of the study was to estimate recurrence rates, time to recurrence, and predisposing factors for recurrence of trigger finger when treated with corticosteroid (CS) injection as primary treatment.

Materials and Methods In a retrospective chart review, we identified primary trigger fingers treated with CS injection as primary treatment. Affected hand and finger, recurrence, time to recurrence, duration of symptoms, secondary treatment type, and comorbidities were recorded. A total of 539 patients were included with a mean follow-up of 47.6 months

Results In total, 330/539 (61%) recurrences were registered. Mean time to recurrence was 312 days. Increased risk of recurrence was seen after treatment of the third finger (relative risk [RR]: 1.22; 95% confidence interval [CI]: 1.06–1.39). Several comorbidities were associated with increased risk of recurrence: carpal tunnel syndrome (RR: 1.27; 95% CI: 1.07–1.52), thyroid disease (RR: 1.45; 95% CI: 1.15–1.83), or shoulder diseases (RR: 1.58; 95% CI: 1.36–1.83).

Conclusion We found a recurrence rate after primary treatment of CS injection for trigger finger of 61%. Most recurrences happened within 2 years and we found treatment of third finger, carpal tunnel syndrome, shoulder, or thyroid disease to be associated with an increased risk of recurrence of symptoms.

Keywords

trigger finger - recurrence - primary treatment - cofactors


Publication History

Article published online:
29 October 2020

© 2020. Society of Indian Hand & Microsurgeons. All rights reserved. Thieme Medical and Scientific Publishers Pvt. Ltd., A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Peters-Veluthamaningal C, van der Windt DA, Winters JC, Meyboom-de Jong B. Corticosteroid injection for trigger finger in adults. Cochrane Database Syst Rev 2009; (01) CD005617
    PubMedGoogle Scholar
  • 2 Koh S, Nakamura S, Hattori T, Hirata H. Trigger digits in diabetes: their incidence and characteristics. J Hand Surg Eur Vol 2010; 35 (04) 302-305
    CrossrefPubMedGoogle Scholar
  • 3 Ryzewicz M, Wolf JM. Trigger digits: principles, management, and complications. J Hand Surg Am 2006; 31 (01) 135-146
    CrossrefPubMedGoogle Scholar
  • 4 Huisstede BMA, Hoogvliet P, Coert JH, Fridén J. European HANDGUIDE Group. Multidisciplinary consensus guideline for managing trigger finger: results from the European HANDGUIDE Study. Phys Ther 2014; 94 (10) 1421-1433
    CrossrefPubMedGoogle Scholar
  • 5 Dardas AZ, VandenBerg J, Shen T, Gelberman RH, Calfee RP. Long-term effectiveness of repeat corticosteroid injections for trigger finger. J Hand Surg Am 2017; 42 (04) 227-235
    CrossrefPubMedGoogle Scholar
  • 6 Dala-Ali BM, Nakhdjevani A, Lloyd MA, Schreuder FB. The efficacy of steroid injection in the treatment of trigger finger. Clin Orthop Surg 2012; 4 (04) 263-268
    CrossrefPubMedGoogle Scholar
  • 7 Schubert C, Hui-Chou HG, See AP, Deune EG. Corticosteroid injection therapy for trigger finger or thumb: a retrospective review of 577 digits. Hand (N Y) 2013; 8 (04) 439-444
    CrossrefPubMedGoogle Scholar
  • 8 Ma S, Wang C, Li J, Zhang Z, Yu Y, Lv F. Efficacy of corticosteroid injection for treatment of trigger finger: a meta-analysis of randomized controlled trials. J Invest Surg 2018; 1-9
    PubMedGoogle Scholar
  • 9 Kongensgaard TB, Schroll L, Hansen RL. [Blind corticosteroid injection as primary treatment of trigger finger]. Ugeskr Laeger 2018; 180 (50) V01180061
    PubMedGoogle Scholar
  • 10 Matthews A, Smith K, Read L, Nicholas J, Schmidt E. Trigger finger: an overview of the treatment options. JAAPA 2019; 32 (01) 17-21
    CrossrefPubMedGoogle Scholar
  • 11 Zhang D, Collins J, Earp BE, Blazar P. Relationship of carpal tunnel release and new onset trigger finger. J Hand Surg Am 2019; 44 (01) 28-34
    CrossrefPubMedGoogle Scholar
  • 12 Lin FY, Wu CI, Cheng HT. Coincidence or complication? A systematic review of trigger digit after carpal tunnel release. J Plast Surg Hand Surg 2018; 52 (02) 67-73
    CrossrefPubMedGoogle Scholar
  • 13 Titchener AG, White JJ, Hinchliffe SR, Tambe AA, Hubbard RB, Clark DI. Comorbidities in rotator cuff disease: a case-control study. J Shoulder Elbow Surg 2014; 23 (09) 1282-1288
    CrossrefPubMedGoogle Scholar
  • 14 Quinnell RC. Conservative management of trigger finger. Practitioner 1980; 224 (1340) 187-190
    Google Scholar
  • 15 Anderson B, Kaye S. Treatment of flexor tenosynovitis of the hand (‘trigger finger’) with corticosteroids. A prospective study of the response to local injection. Arch Intern Med 1991; 151 (01) 153-156
    CrossrefPubMedGoogle Scholar
  • 16 Marks MR, Gunther SF. Efficacy of cortisone injection in treatment of trigger fingers and thumbs. J Hand Surg Am 1989; 14 (04) 722-727
    CrossrefPubMedGoogle Scholar
  • 17 Newport ML, Lane LB, Stuchin SA. Treatment of trigger finger by steroid injection. J Hand Surg Am 1990; 15 (05) 748-750
    CrossrefPubMedGoogle Scholar
  • 18 Wojahn RD, Foeger NC, Gelberman RH, Calfee RP. Long-term outcomes following a single corticosteroid injection for trigger finger. J Bone Joint Surg Am 2014; 96 (22) 1849-1854
    CrossrefPubMedGoogle Scholar
  • 19 Hansen RL, Søndergaard M, Lange J. Open surgery versus ultrasound-guided corticosteroid injection for trigger finger: a randomized controlled trial with 1-year follow-up. J Hand Surg Am 2017; 42 (05) 359-366
    CrossrefPubMedGoogle Scholar
  • 20 Kerrigan CL, Stanwix MG. Using evidence to minimize the cost of trigger finger care. J Hand Surg Am 2009; 34 (06) 997-1005
    CrossrefPubMedGoogle Scholar
  • 21 Kumar P, Chakrabarti I. Idiopathic carpal tunnel syndrome and trigger finger: is there an association?. J Hand Surg Eur Vol 2009; 34 (01) 58-59
    CrossrefPubMedGoogle Scholar
  • 22 Cakir M, Samanci N, Balci N, Balci MK. Musculoskeletal manifestations in patients with thyroid disease. Clin Endocrinol (Oxf) 2003; 59 (02) 162-167
    CrossrefPubMedGoogle Scholar